fig6

Unveiling MAGEA3: a novel predictive biomarker for bevacizumab resistance in colorectal cancer

Figure 6. MAGEA3 regulates the mitochondrial capacity of CRC cell lines. (A and B) The extracellular acidification rate (A) and oxygen consumption rate (B) of shNC and shMAGEA3 HCT116 cell lines in Seahorse experiment; (C and D) The extracellular acidification rate (C) and oxygen consumption rate (D) of HT29 cell lines overexpressing EGFP and MAGEA3 in Seahorse experiment. ns: no significance, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. shNC: shRNA for negative control; MAGEA3-OE: MAGEA3 overexpression.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/